Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer.

Area of Science:

• Gastroenterology
• Oncology
• Preventive Medicine

Background:

• Colonoscopic surveillance is crucial for individuals with familial colorectal cancer (CRC).
• Determining the optimal screening interval for this high-risk group remains a challenge.
• This study addresses the need for evidence-based surveillance guidelines.

Purpose of the Study:

• To compare the efficacy of a 3-year versus a 6-year colonoscopic screening interval.
• To evaluate the incidence of advanced adenomatous polyps (AAPs) in familial CRC cases.
• To inform optimal surveillance strategies for individuals at high risk for CRC.

Main Methods:

• A randomized trial involving 528 individuals aged 45-65 with a family history of CRC.
• Patients with zero to two baseline adenomas were assigned to 6-year (Group A) or 3-year (Group B) surveillance intervals.
• Primary outcome was the detection rate of advanced adenomatous polyps (AAPs).

Main Results:

• No significant difference in AAP detection rates between 6-year and 3-year intervals at initial or final follow-up.
• Baseline AAPs were a significant predictor of future AAP development.
• After adjusting for baseline findings, differences in AAP rates between groups were statistically significant.

Conclusions:

• A 6-year colonoscopic surveillance interval is considered appropriate for familial CRC cases with low baseline risk.
• A shorter 3-year interval may be warranted for patients with existing AAPs or multiple adenomas.
• Findings support personalized surveillance strategies based on individual risk factors.